Beam Therapeutics Inc.BEAMNASDAQ
Loading
Debt to Equity Over TimeElevated
Percentile Rank63
3Y CAGR-0.9%
5Y CAGR-11.5%
Studio
Year-over-Year Change

Debt-to-equity ratio

3Y CAGR
-0.9%/yr
Annual compound
5Y CAGR
-11.5%/yr
Recent acceleration
Percentile
P63
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
2 yr
Consecutive growthElevated
PeriodValueYoY Change
20250.24+7.8%
20240.22+25.1%
20230.18-27.9%
20220.24+36.7%
20210.18-59.3%
20200.44+41.7%
20190.31-
20180.00+100.0%
2017-0.24-